Purchase Order 75D30122P15534
Award Date 9/19/22
Potential Completion Date 12/31/22
Potential Value $96K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The $54,000 contract is for the maintenance of a medium throughput DNA synthesizer and 42 related reagents. The award was not set aside for any specific business category. Biolytic Lab Performance Inc. specializes in providing scientific instrumentation, particularly oligonucleotide synthesizers...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned, for-profit organization that specializes in DNA synthesis solutions. The contract, valued at $56,000.00, is for the maintenance of Biolytic's DR. OLIGO 48 DNA synthesizers. The contract has a completion date of February 9, 2026. Biolytic Lab Performance Inc. has extensive experience providing DNA synthesizers, related instruments,...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit organization. The contract, valued at $84,950.00, is for the provision of an OLIGO INST (oligonucleotide instrument), with a performance period ending on July 20, 2021. The contract has no set-aside designation. Biolytic Lab Performance Inc. is a provider of DNA synthesis solutions and laboratory equipment, having secured...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order, contract number 75D30120P09399, to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for a maintenance agreement covering a Biolytic DNA synthesizer. The $28,100 contract has an ultimate completion date of August 16, 2023. The contract was awarded without a set-aside on August 17, 2020, based on a sole-source solicitation. Biolytic Lab Performance is the only company...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh has awarded a $56,160 firm fixed-price purchase order to Biolytic Lab Performance Inc., a veteran-owned laboratory equipment specialist based in Fremont, California, for annual maintenance services on DNA synthesizer systems. The contract, awarded on September 30, 2025, with an ultimate completion date of September 29, 2027, covers maintenance and support for the BLP 3900 and BLP Dr. Oligo 48 synthesizer systems. The procurement was...
- This is a sole source purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Agilent Technologies Inc. for the procurement of Oligo Pro II supplies or services. The contract action is being pursued under the authority of FAR 13.106-1(b) and 41 U.S.C. 3304(a)(1), which allows for sole source procurement without competition. The key requirements include fast separations, wide sizing range, single base resolution through 60-mers, variable throughput, and direct...
- This is a $32,000.00 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Bioinforx, Inc., a small disadvantaged business. The contract is for the bulk procurement of oligos, with a period of performance ending on September 30, 2020. Bioinforx, Inc. is a for-profit organization that specializes in developing scientific data management systems and laboratory information technologies, particularly for government health agencies like the CDC and the...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded Biolytic Lab Performance Inc., a for-profit, veteran-owned business, a firm-fixed-price purchase order contract for $42,600.00. The contract is for an annual service agreement with a completion date of August 9, 2025. The original solicitation was for 500 mL of Avantor Seradigm Premium Grade Fetal Bovine Serum. This contract does not have a set-aside designation. Biolytic Lab Performance...
- This is a $16,438.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the delivery of custom laboratory oligonucleotides. The contract has no set-aside designation. IDT is a leading manufacturer and supplier of specialized nucleic acid products and services to federal agencies, supporting initiatives such as biomedical research, pandemic response, and public health programs. This award is part of...
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to CSBIO Instrumentation Co. for the procurement of a CSBIO Fully Automated Peptide Synthesizer. The $58,732.50 contract has an ultimate completion date of August 31, 2024. The synthesizer must have a 20 mL jacketed reaction vessel with automated software-integrated heating and cooling capabilities ranging from -20°C to 90°C, a requirement that the CDC has determined only CSBIO's CS136X model...